CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DYE-LIGHT project aims to enhance the delivery of biotherapeutics for ocular diseases by utilizing novel techniques involving pulsed-lasers and dye-based nanobubbles. This approach seeks to improve safety and efficacy in drug and gene delivery to the eye, potentially transforming treatment options for patients with…
Ocular diseases affect the quality of life of millions of patients.
Despite improvements in pharmacological treatments, the arsenal of medications to treat severe ocular diseases today remains rather restricted to traditional drugs.
Use of most modern biotherapeutics like proteins and nucleic acids, could be a major step forward.
However, current ways of administration such as eye drops and intravitreal injections, are no longer sufficient to deliver these drugs to most targets in the eye.
There…
UNIVERSITEIT GENT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
